Oncology
Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer
Taiho Oncology, Inc.
PR-M05-18-NI-045May 11, 2018
Endpoint
Phase III Study Evaluating the Efficacy and Safety of Lonsurf in Patients with Metastatic Gastric Cancer Meets Primary Endpoint
Servier
PR-M05-18-NI-040May 10, 2018